company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1657000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1657000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2132000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2132000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-475000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5795000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1397000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4292000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11484000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11959000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,523000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,19367000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18856000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6897000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6884000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6884000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6884000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1490544.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q2,2010-04-01,2010-06-30,2011-09-02 17:05:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12363578.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,689000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,689000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,737000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,737000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-48000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3880000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1955000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5721000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11556000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11604000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1031000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,164000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-867000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12471000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12487000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12487000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12487000.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1490551.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1490551.0
Horizon Pharma PLC,HZNP,,0001492426,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 10:49:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1490551.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1793000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1793000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1839000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1839000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-46000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3098000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1117000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2729000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6944000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6990000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1285000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,422000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-863000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7853000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-182000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7671000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7671000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7671000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1493962.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1493962.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:08:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1493962.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1335000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1335000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2104000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2104000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-769000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3348000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1169000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3462000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7979000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8748000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3185000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,110000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3075000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11823000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-186000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11637000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11637000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11637000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1496278.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q2,2011-04-01,2011-06-30,2011-09-02 17:05:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1496278.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,273000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,273000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1249000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1249000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-976000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4192000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5141000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5346000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14679000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15655000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,995000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-758000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1753000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17408000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-177000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17231000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17231000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17231000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13256189.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13256189.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 10:49:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13256189.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3538000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-12000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3526000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2075000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2075000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1451000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4370000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12887000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3821000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,69621000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90699000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-89248000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,819000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-797000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1616000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-90864000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-14138000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-76726000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-76726000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-76726000.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9014968.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9014968.0
Horizon Pharma PLC,HZNP,,0001492426,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9014968.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2722000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-199000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2523000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2067000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2067000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,456000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5203000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,10972000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4069000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20244000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19788000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4551000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,449000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4102000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23890000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-164000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23726000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23726000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23726000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24116490.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24116490.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:08:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24116490.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4608000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-767000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3841000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2855000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2855000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,986000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4555000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,10543000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4233000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19331000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18345000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3191000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1405000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4596000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22941000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-159000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22782000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22782000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22782000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33715703.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33715703.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 07:19:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33715703.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7311000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-790000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6521000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3810000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3810000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2711000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4678000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12951000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3796000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21425000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18714000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3339000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,588000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2751000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21465000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4512000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16953000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16953000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16953000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35972657.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35972657.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 07:11:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35972657.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4203000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1756000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5959000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3143000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3143000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2816000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5008000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15095000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4739000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24842000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22026000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,471000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2172000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2643000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24669000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-336000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24333000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24333000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24333000.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38871422.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38871422.0
Horizon Pharma PLC,HZNP,,0001492426,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38871422.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10698000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1527000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9171000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4247000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4247000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4924000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5200000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16070000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2198000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23468000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18544000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3603000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-905000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4508000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23052000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-881000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22171000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22171000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22171000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61939822.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61939822.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 06:48:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61939822.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11131000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11131000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2394000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2394000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8737000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5182000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16526000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2833000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24541000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15804000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3442000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,454000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2988000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18792000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-351000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18441000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18441000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18441000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62872173.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62872173.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:51:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62872173.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24112000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24112000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3207000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3207000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20905000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5874000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15621000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2154000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23649000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2744000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3601000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1118000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2483000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5227000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,265000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5492000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5492000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5492000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64645677.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64645677.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68700000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 07:31:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28075000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1527000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29602000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4777000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4777000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24825000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7310000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,20378000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2899000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30587000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5762000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-10646000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-12774000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-95165000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-97293000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-103055000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-154000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-102901000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102901000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-102901000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63657924.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.26
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63657924.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.26
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63700000.0
Horizon Pharma PLC,HZNP,,0001492426,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.26
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51926000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51926000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7619000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7619000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44307000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11192000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,28695000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2833000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42720000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1587000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4207000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-204735000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-208942000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-207355000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1105000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-206250000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-206250000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-206250000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67138463000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67138463000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 08:10:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67138463000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66062000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66062000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24810000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24810000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41252000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17681000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,27126000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3545000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48352000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7100000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4207000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15582000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19789000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26889000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,880000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27769000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27769000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27769000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73384801.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73384801.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73100000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 07:20:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75126000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75126000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13644000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13644000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61482000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38109000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,31111000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4223000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73443000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11961000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5194000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16176000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10982000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-979000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3042000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2063000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2063000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2063000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78392971.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85687267.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68800000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 07:27:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,103841000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,103841000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32680000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32680000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,71161000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21975000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,33344000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6859000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62178000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8983000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-8414000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18632000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-33229000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-43447000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34464000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2817000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31647000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31647000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31647000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83751129.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.8
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83751129.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.79
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83700000.0
Horizon Pharma PLC,HZNP,,0001492426,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.8
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,113141000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,113141000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28853000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28853000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84288000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26280000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,47063000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6181000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79524000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4764000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-10032000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12372000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22404000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17640000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1913000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19553000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19553000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19553000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125650593.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125650593.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 07:11:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,125650593.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,172821000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,172821000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61826000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61826000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110995000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77190000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,58056000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8922000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,144168000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33173000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19448000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-76245000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-95693000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-128866000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-160680000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31814000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31814000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31814000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,150771902.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,159797319.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,151500000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 07:30:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,226544000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,226544000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61250000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61250000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,165294000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54516000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,51973000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13073000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,119562000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45732000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-20300000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-176000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20476000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25256000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,21979000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3277000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3277000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3277000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,159035580.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,166830800.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,163900000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 07:28:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,244538000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,244538000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,67573000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,67573000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,176965000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,282319000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-157092000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13689000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,138916000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38049000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-49152000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-359000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49511000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11462000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-35456000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23994000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23994000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23994000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,148788020.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155923251.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,146400000.0
Horizon Pharma PLC,HZNP,,0001492426,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,204690000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,204690000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,77233000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,77233000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,127457000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,141939000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12722000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,154661000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27204000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19458000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-187000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19645000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46849000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1443000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45406000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45406000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45406000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,159904416.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,159904416.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 07:30:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,159904416.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,257378000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,257378000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,81126000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,81126000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,176252000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,133575000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11210000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,144785000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31467000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19228000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19239000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12228000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2756000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14984000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14984000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14984000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,160468146.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,163920581.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,166500000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 07:21:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,208702000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,208702000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,85161000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,85161000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123541000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,132049000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12814000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,144863000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21322000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-19066000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6771000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12295000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33617000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-27747000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5870000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5870000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5870000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,161038827.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,161038827.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 07:22:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,161038827.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,310350000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,310350000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,148481000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,148481000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,161869000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,195485000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23961000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,71260000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,290706000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-128837000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-28858000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-881000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29739000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-158576000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-29305000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-129271000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-129271000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-129271000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,160700000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.12
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,160700000.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.12
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,160699543.0
Horizon Pharma PLC,HZNP,,0001492426,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.12
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,220859000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,220859000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,139116000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,139116000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81743000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,174065000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13061000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,187126000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-105383000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31983000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-757000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32740000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-138123000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-47553000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90570000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90570000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-90570000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,161972052.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,161972052.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:29:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,161972052.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,289507000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,289507000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,130150000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,130150000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,159357000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,159653000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,163101000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,22270000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,345024000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-185667000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31608000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5972000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25636000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-211303000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1767000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-209536000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-209536000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-209536000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,162931930.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,162931930.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 07:24:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,162931930.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,271646000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,271646000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,125517000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,125517000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146129000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,153952000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17928000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,171880000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25751000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31706000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,667000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-31039000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-56790000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7181000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63971000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63971000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-63971000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,163447208.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,163447208.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,164000000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 08:13:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,274219000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,274219000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98585000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98585000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,175634000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,167423000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30872000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,198295000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22661000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31226000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1292000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29934000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52595000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-66547000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13952000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13952000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13952000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,163122663.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.76
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,163122663.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.76
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,162800000.0
Horizon Pharma PLC,HZNP,,0001492426,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.76
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,223881000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,223881000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,110288000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,110288000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,113593000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,179599000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17645000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,33647000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,230891000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-117298000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-30454000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,41000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30413000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-147711000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,945000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-148656000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-148656000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-148656000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,165200000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.9
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,165200000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.9
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,164549502.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 07:13:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.9
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,302835000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,302835000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,91337000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,91337000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,211498000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,176674000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24265000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200939000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10559000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-31030000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,341000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30689000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20130000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4600000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24730000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24751000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24751000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,165000000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,165000000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,165536826.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 07:21:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,325311000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,325311000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,91077000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,91077000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,234234000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,161585000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21169000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1603000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-12303000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,172054000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62180000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-30437000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,372000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30065000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32115000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1266000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33381000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33381000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33381000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,167047104.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,172485757.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,166900000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 07:17:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,355543000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,355543000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98599000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98599000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,256944000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,174627000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19683000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,10846000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-30682000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,174474000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,82470000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-29771000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-105000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29876000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,52594000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-49031000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,101625000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,101646000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,101646000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,166155405.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.62
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,166155405.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,166900000.0
Horizon Pharma PLC,HZNP,,0001492426,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.62
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,280371000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,280371000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,88142000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,88142000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,192229000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,172299000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21725000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,194024000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1795000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-27530000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5458000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32988000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34783000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1920000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32863000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32863000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32863000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,173000000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,173000000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,172789209.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:17:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,320647000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,320647000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,89163000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,89163000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,231484000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,167095000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28314000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,10963000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,206372000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25112000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-22033000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13074000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35107000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9995000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4900000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5095000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5120000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5120000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,170700000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,170700000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,185327383.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 07:21:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,335466000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,335466000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,89949000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,89949000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,245517000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,172326000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24572000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,196898000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,48619000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-20428000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-40521000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-60949000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12330000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-30564000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18234000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18234000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18234000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,186470141.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194171967.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182300000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 07:17:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,363545000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,363545000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,94921000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,94921000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,268624000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,185391000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28558000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-10963000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10963000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,213949000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54675000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-17098000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-693000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17791000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36884000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-555860000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,592744000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,592769000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,592769000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,182930109.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.25
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,205224221.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.03
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,183100000.0
Horizon Pharma PLC,HZNP,,0001492426,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.25
